Senator Investment Group’s Adaptive Biotechnologies ADPT Stock Holding History

Senator Investment Group’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-500,000	Closed	-$3.35M	–	55
2023 Q2	$3.35M	Hold	500,000	–	–	0.15%	50
2023 Q1	$4.42M	Sell	500,000 -500,000	-50%	-$4.41M	0.24%	43
2022 Q4	$7.64M	Hold	1,000,000	–	–	0.69%	36
2022 Q3	$7.12M	Hold	1,000,000	–	–	0.65%	40
2022 Q2	$8.09M	Hold	1,000,000	–	–	0.58%	38
2022 Q1	$13.9M	Hold	1,000,000	–	–	0.43%	45
2021 Q4	$28.1M	Hold	1,000,000	–	–	0.54%	49
2021 Q3	$34M	Hold	1,000,000	–	–	0.58%	57
2021 Q2	$40.9M	Hold	1,000,000	–	–	0.78%	48
2021 Q1	$40.3M	Sell	1,000,000 -250,000	-20%	-$13.5M	0.83%	44
2020 Q4	$73.9M	Sell	1,250,000 -500,000	-29%	-$25.8M	1.4%	23
2020 Q3	$85.1M	Buy	1,750,000 +100,000	+6%	+$4.2M	2.48%	12
2020 Q2	$79.8M	Sell	1,650,000 -1,738,085	-51%	-$63.4M	2.76%	12
2020 Q1	$94.1M	Sell	3,388,085 -1,725,000	-34%	-$48.1M	3.41%	13
2019 Q4	$153M	Hold	5,113,085	–	–	4.19%	4
2019 Q3	$146M	Hold	5,113,085	–	–	3.67%	9
2019 Q2	$210M	Buy	+5,113,085	New	+$227M	3.86%	5

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Senator Investment Group's ADPT Position: Q3 2023 in Review

Senator Investment Group sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 500,000 shares — an estimated $3.35M sold.

Senator Investment Group first reported a position in ADPT in Q2 2019 and held it in 17 quarters. The position peaked at $210M in Q2 2019. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

Senator Investment Group reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
Senator Investment Group sold 500,000 Adaptive Biotechnologies shares in Q3 2023, an estimated $3.35M.
Senator Investment Group first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 17 quarters.
Senator Investment Group's Adaptive Biotechnologies position peaked at $210M in Q2 2019.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on Senator Investment Group's 13F filing for Q3 2023, filed 14 Nov 2023.